术后患者无创呼吸支持效果:系统评价与网络荟萃分析
这项系统评价与网络荟萃分析纳入33项随机和非随机对照试验、共11,292例术后拔管成人患者,比较无创呼吸支持(高流量鼻氧、持续气道正压、无创通气)与常规氧疗的效果。主要终点再插管率方面,仅无创通气较常规氧疗显著降低(OR 0.49,95%CI 0.28–0.87,p=0.015,I²=60.5%,低证据确定性),且该效果见于以治疗为目的、以及拔管后呼吸衰竭高危患者,预防性使用和低危患者未见此效果。无创通气还降低院内肺炎发生率、ICU住院时间及ICU、医院和长期死亡率,未加重患者不适。
要点
- 术后拔管成人中,仅无创通气较常规氧疗降低再插管率(OR 0.49,95%CI 0.28–0.87,p=0.015,I²=60.5%,低证据确定性)。
- 无创通气降低再插管率的效果见于治疗已发生的拔管后呼吸衰竭患者,预防性使用未见此效果。
- 无创通气降低再插管率的效果见于拔管后呼吸衰竭高危患者,低危患者未见此效果。
- 无创通气还降低院内肺炎发生率、ICU住院时间及ICU、医院和长期死亡率,未加重患者不适。
适用人群与场景
- 术后拔管成人患者;证据覆盖以治疗为目的和以预防为目的使用无创呼吸支持者,以及拔管后呼吸衰竭高危和低危患者。
处置流程与药物剂量
- 在术后拔管患者中,无创通气用于治疗已发生的拔管后呼吸衰竭时较常规氧疗降低再插管率(OR 0.49,95%CI 0.28–0.87,p=0.015,I²=60.5%,低证据确定性)。
- 在拔管后呼吸衰竭高危的术后患者中,无创通气较常规氧疗降低再插管率;低危患者未见此效果。
- 无创通气较常规氧疗降低院内肺炎发生率、ICU住院时间及ICU、医院和长期死亡率,未加重患者不适。
研究设计与关键结果
- 系统评价与网络荟萃分析纳入33项随机和非随机对照试验、共11,292例术后拔管成人患者,检索Medline、Embase、Scopus、Cochrane Central Register of Controlled Trials和Web of Science自建库至2024年2月2日。
- 主要终点再插管率:在所有无创呼吸支持方式中,仅无创通气较常规氧疗降低再插管率(OR 0.49,95%CI 0.28–0.87,p=0.015,I²=60.5%,低证据确定性)。
- 亚组分析显示,无创通气降低再插管率的效果见于以治疗为目的使用(而非以预防为目的使用)的患者,以及拔管后呼吸衰竭高危患者(而非低危患者)。
- 次要终点:无创通气降低院内肺炎发生率、ICU住院时间及ICU、医院和长期死亡率,未加重患者不适。
证据类型、等级与局限
- 证据类型:系统评价与网络荟萃分析,纳入随机和非随机对照试验。
- 再插管率结果的证据确定性为低(low certainty of evidence)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在术后拔管接受无创呼吸支持的患者中,当无创通气用于治疗拔管后呼吸衰竭及用于拔管后呼吸衰竭高危患者时,较常规氧疗降低再插管率。
- 术后拔管患者以预防为目的使用无创通气、或拔管后呼吸衰竭低危患者,未见无创通气较常规氧疗降低再插管率。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Re-intubation secondary to post-extubation respiratory failure in post-operative patients is associated with increased patient morbidity and mortality. Non-invasive respiratory support (NRS) alternative to conventional oxygen therapy (COT), i.e., high-flow nasal oxygen, continuous positive airway pressure, and non-invasive ventilation (NIV), has been proposed to prevent or treat post-extubation respiratory failure. Aim of the present study is assessing the effects of NRS application, compared to COT, on the re-intubation rate (primary outcome), and time to re-intubation, incidence of nosocomial pneumonia, patient discomfort, intensive care unit (ICU) and hospital length of stay, and mortality (secondary outcomes) in adult patients extubated after surgery.
METHODS: A systematic review and network meta-analysis of randomized and non-randomized controlled trials. A search from Medline, Embase, Scopus, Cochrane Central Register of Controlled Trials, and Web of Science from inception until February 2, 2024 was performed.
RESULTS: Thirty-three studies (11,292 patients) were included. Among all NRS modalities, only NIV reduced the re-intubation rate, compared to COT (odds ratio 0.49, 95% confidence interval 0.28; 0.87, p = 0.015, I2 = 60.5%, low certainty of evidence). In particular, this effect was observed in patients receiving NIV for treatment, while not for prevention, of post-extubation respiratory failure, and in patients at high, while not low, risk of post-extubation respiratory failure. NIV reduced the rate of nosocomial pneumonia, ICU length of stay, and ICU, hospital, and long-term mortality, while not worsening patient discomfort.
CONCLUSIONS: In post-operative patients receiving NRS after extubation, NIV reduced the rate of re-intubation, compared to COT, when used for treatment of post-extubation respiratory failure and in patients at high risk of post-extubation respiratory failure.
参考来源
- Pettenuzzo T, Boscolo A, Pistollato E, et al. Effects of non-invasive respiratory support in post-operative patients: a systematic review and network meta-analysis. Crit Care. 2024. PMID: 38720332. doi:10.1186/s13054-024-04924-0
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。